JB Chemicals & Pharmaceuticals manufactures a wide range of pharmaceutical formulation specialties, radio-diagnostics, APIs, and intermediates.
The company's consolidated net profit rose 15.5% to Rs 145.69 crore on a 10.2% rise in revenue to Rs 949.48 crore in Q4 FY25, compared with Q4 FY24.
Shares of JB Chemicals & Pharmaceuticals rose 0.10% to Rs 1,800.60 on the BSE.
Powered by Capital Market - Live News